Oncternal Therapeutics (NASDAQ:ONCT) Earns Sell Rating from

StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a report published on Monday. The firm issued a sell rating on the stock. A number of other brokerages have also recently issued reports on ONCT. Oppenheimer cut shares of Oncternal Therapeutics from an outperform rating to a market perform rating in […]

Related Keywords

San Diego , California , United States , Jamesb Breitmeyer , Davidf Hale , , Healthcare Of Ontario Pension Plan Trust Fund , Maxim Group , Cantor Fitzgerald , Waypoint Capital Advisors , Renaissance Technologies , Oncternal Therapeutics Inc , Oncternal Therapeutics , Get Rating , Capital Management , Capital Acquisition , Therapeutics Stock Down , Capital Advisors , Ontario Pension Plan Trust Fund , Sigma Investments , Two Sigma Advisers , Sigma Advisers , Oncternal Therapeutics Daily , Nasdaq Onct , Conct , Medical , Initiated Coverage , Stocknews Com ,